{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:43:34Z","timestamp":1773935014310,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jfas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Foot and Ankle Surgery"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1053\/j.jfas.2020.09.018","type":"journal-article","created":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T12:02:35Z","timestamp":1606910555000},"page":"354-357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Investigating the Use of Denosumab in the Treatment of Acute Charcot Neuroarthropathy"],"prefix":"10.1053","volume":"60","author":[{"given":"David","family":"Shofler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elnaz","family":"Hamedani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Seun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Airani","family":"Sathananthan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Katsaros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsey","family":"Liggan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirley","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christal","family":"Pham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.jfas.2020.09.018_bib0001","first-page":"4","article-title":"Charcot foot and ankle with osteomyelitis","author":"Donegan","year":"2013","journal-title":"Diabet Foot Ankle"},{"key":"10.1053\/j.jfas.2020.09.018_bib0002","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jdiacomp.2016.01.004","article-title":"The impact of comorbidities on inpatient Charcot neuroarthropathy cost and utilization","volume":"30","author":"Labovitz","year":"2016","journal-title":"J Diabetes Complications"},{"key":"10.1053\/j.jfas.2020.09.018_bib0003","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/S0140-6736(05)67029-8","article-title":"The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes","volume":"366","author":"Jeffcoate","year":"2005","journal-title":"Lancet"},{"key":"10.1053\/j.jfas.2020.09.018_bib0004","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1757-1146-6-11","article-title":"Neuropathic midfoot deformity: associations with ankle and subtalar joint motion","volume":"6","author":"Sinacore","year":"2013","journal-title":"J Foot Ankle Res"},{"key":"10.1053\/j.jfas.2020.09.018_bib0005","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.dsx.2013.02.029","article-title":"Morphofunctional characteristics of the foot in patients with diabetes mellitus and diabetic neuropathy","volume":"7","author":"Garc\u00eda-\u00c1lvarez","year":"2013","journal-title":"Diabetes Metab Syndr"},{"key":"10.1053\/j.jfas.2020.09.018_bib0006","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.mcna.2013.04.003","article-title":"The Charcot foot","volume":"97","author":"Rogers","year":"2013","journal-title":"Med Clin North Am"},{"key":"10.1053\/j.jfas.2020.09.018_bib0007","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1053\/j.semvascsurg.2012.05.001","article-title":"Diabetic foot ulcerations: biomechanics, charcot foot, and total contact cast","volume":"25","author":"Malhotra","year":"2012","journal-title":"Semin Vasc Surg"},{"key":"10.1053\/j.jfas.2020.09.018_bib0008","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cpm.2013.09.007","article-title":"Charcot Neuroarthropathy of the foot and ankle: diagnosis and management strategies","volume":"31","author":"Blume","year":"2014","journal-title":"Clin Podiatr Med Surg"},{"key":"10.1053\/j.jfas.2020.09.018_bib0009","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.2337\/dc11-0396","article-title":"The effect of zoledronic acid on the clinical resolution of Charcot neuroarthropathy: a pilot randomized controlled trial","volume":"34","author":"TK1","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1053\/j.jfas.2020.09.018_bib0010","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1007\/s001250100008","article-title":"Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial","volume":"44","author":"Jude","year":"2001","journal-title":"Diabetologia"},{"key":"10.1053\/j.jfas.2020.09.018_bib0011","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.mcna.2013.05.002","article-title":"Pathogenesis and medical management of diabetic Charcot neuroarthropathy","volume":"97","author":"Mascarenhas","year":"2013","journal-title":"Med Clin North Am"},{"key":"10.1053\/j.jfas.2020.09.018_bib0012","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jdiacomp.2018.04.010","article-title":"A review of bone metabolism and developments in medical treatment of the diabetic Charcot foot","volume":"32","author":"Jansen","year":"2018","journal-title":"J Diabetes Complications"},{"key":"10.1053\/j.jfas.2020.09.018_bib0013","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1056\/NEJMoa044459","article-title":"Denosumab in postmenopausal women with low bone mineral density","volume":"354","author":"McClung","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jfas.2020.09.018_bib0014","first-page":"593","article-title":"Osteoporosis in men: epidemiology and treatment with denosumab","volume":"9","author":"Sidlauskas","year":"2014","journal-title":"Clin Interv Aging"},{"key":"10.1053\/j.jfas.2020.09.018_bib0015","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.bone.2011.08.007","article-title":"A randomized, double-blind, placebo-controlled, single-dose study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of denosumab administered subcutaneously to postmenopausal Japanese women","volume":"49","author":"Kumagai","year":"2011","journal-title":"Bone"},{"key":"10.1053\/j.jfas.2020.09.018_bib0016","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jfas.2020.09.018_bib0017","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.clinthera.2012.02.002","article-title":"Role of RANK ligand and denosumab, a targeted RANK ligand inhibitor, in bone health and osteoporosis: a review of preclinical and clinical data","volume":"34","author":"Dempster","year":"2012","journal-title":"Clin Ther"},{"key":"10.1053\/j.jfas.2020.09.018_bib0018","doi-asserted-by":"crossref","first-page":"e1674","DOI":"10.1097\/MD.0000000000001674","article-title":"Efficacy and safety of denosumab in postmenopausal women with osteoporosis: a meta-analysis","volume":"94","author":"Gu","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1053\/j.jfas.2020.09.018_bib0019","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jfas.2020.09.018_bib0020","series-title":"Conference: Diabetic Foot Australia Conference 2017 At","article-title":"Preliminary (12-week) results from trial of denosumab for acute diabetic Charcot neuroarthropathy","author":"Lau","year":"2017"},{"key":"10.1053\/j.jfas.2020.09.018_bib0021","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.2337\/dc17-1517","article-title":"Effect of single dose of RANKL antibody treatment on acute Charcot neuro-osteoarthropathy of the foot","volume":"41","author":"Busch-Westbroek","year":"2018","journal-title":"Diabetes Care"}],"container-title":["The Journal of Foot and Ankle Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1067251620304361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1067251620304361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T05:10:08Z","timestamp":1761023408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1067251620304361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1067251620304361"],"URL":"https:\/\/doi.org\/10.1053\/j.jfas.2020.09.018","relation":{},"ISSN":["1067-2516"],"issn-type":[{"value":"1067-2516","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigating the Use of Denosumab in the Treatment of Acute Charcot Neuroarthropathy","name":"articletitle","label":"Article Title"},{"value":"The Journal of Foot and Ankle Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jfas.2020.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American College of Foot and Ankle Surgeons. All rights reserved.","name":"copyright","label":"Copyright"}]}}